ArticleJAMA ophthalmology2025
Outcomes of Trabeculectomy With Mitomycin C in Patients of Hispanic vs European Descent.
Article in JAMA ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Two-year efficacy and safety outcomes of the Paul Glaucoma Implant compared to the Ahmed Glaucoma Valve.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Article
Corrections and comments
- Commented on by
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Previous studies suggest that race or ethnicity may influence glaucoma surgical outcomes. Objective: To compare outcomes of initial trabeculectomy with mitomycin C (MMC) in patients of Hispanic descent with those in patients of European descent and identify prognostic factors for failure. Design, Setting, and Participants: This retrospective matched-cohort study was conducted at a single-tertiary academic center. The study included 111 eyes from 96 patients of Hispanic descent that were matched to 111 eyes from 108 patients of European descent, based on age (±5 years), surgeon, lens status, and surgery date (±1 year). Ethnicity was self-determined by patients. Exposure: Initial trabeculectomy with MMC. Main Outcome Measures: Criteria A, B, and C defined qualified success as final intraocular pressure (IOP) of 18 mm Hg or less, 15 mm Hg or less, and 12 mm Hg or less, respectively, with corresponding IOP reduction of 20% or more, 25% or more, and 30% or more, or a decrease of 2 or more medications. Complete success required meeting the above criteria without medication use. Kaplan-Meier survival curves compared patients of Hispanic descent and patients of European descent success rates with log-rank tests. Cox proportional hazard models estimated the influence of ethnicity on surgical success adjusting for confounders. Results: The Hispanic descent cohort included 59 females (61.5%) and 37 males (38.5%) with a mean (SD) age of 69.1 (9.9) years. The European descent cohort included 53 females (49.1%) and 55 males (50.9%) with a mean (SD) age of 69.2 (9.4) years. Qualified success rates at 5 years in Hispanic descent and European descent patients were 52% and 68% based on criteria A (difference, 16.7%; 95% CI, 4.0%-29.4%; P < .001), 45% and 61% according to criteria B (difference, 16.2%; 95% CI, 3.2%-29.1%; P = .01), and 31% and 51% based on criteria C (difference, 20.0%; 95% CI, 7.3%-32.6%; P = .002). On multivariable analyses, Hispanic descent was associated with higher failure rates with all complete and qualified success criteria (hazard ratio range, 2.07-3.03; P < .001). Early bleb leaks were more frequent in patients of Hispanic descent (14 eyes vs 6 eyes; P = .10). Conclusion and Relevance: In this study, Hispanic descent was associated with higher failure rate after initial trabeculectomy with adjunctive MMC compared with European descent. These findings need to be considered when glaucoma surgery is contemplated in patients of Hispanic descent, especially if these findings are confirmed in future studies that address some of the limitations of this single-center retrospective investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.